» Articles » PMID: 17998229

How Does Early Chronic Kidney Disease Progress? A Background Paper Prepared for the UK Consensus Conference on Early Chronic Kidney Disease

Overview
Date 2007 Dec 6
PMID 17998229
Citations 34
Authors
Affiliations
Soon will be listed here.
Citing Articles

The Leicester, Leicestershire and Rutland quality improvement project and integrated chronic kidney disease system: implementation within a primary care network.

Rizvi F, Lakhani N, Omuri L, Roshan S, Kapasi T, White S BMC Nephrol. 2024; 25(1):255.

PMID: 39118047 PMC: 11312582. DOI: 10.1186/s12882-024-03668-x.


Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non-diabetic chronic kidney disease.

Cooper T, Teng C, Tunnicliffe D, Cashmore B, Strippoli G Cochrane Database Syst Rev. 2023; 7:CD007751.

PMID: 37466151 PMC: 10355090. DOI: 10.1002/14651858.CD007751.pub3.


Visit-to-visit variability in albuminuria predicts renal function deterioration in patients with type 2 diabetes.

Lin C, Lai Y, Chang T, Jiang Y, Chang Y, Chuang L J Diabetes Investig. 2022; 13(6):1021-1029.

PMID: 35100497 PMC: 9153848. DOI: 10.1111/jdi.13761.


Chronic Kidney Disease and SGLT2 Inhibitors: A Review of the Evolving Treatment Landscape.

Mende C Adv Ther. 2021; 39(1):148-164.

PMID: 34846711 PMC: 8799531. DOI: 10.1007/s12325-021-01994-2.


TDAG51 induces renal interstitial fibrosis through modulation of TGF-β receptor 1 in chronic kidney disease.

Carlisle R, Mohammed-Ali Z, Lu C, Yousof T, Tat V, Nademi S Cell Death Dis. 2021; 12(10):921.

PMID: 34625532 PMC: 8501078. DOI: 10.1038/s41419-021-04197-3.